329 related articles for article (PubMed ID: 27692597)
1. Usefulness of Serial N-terminal Pro-B-type Natriuretic Peptide Measurements to Predict Cardiac Death in Acute and Chronic Dilated Cardiomyopathy in Children.
den Boer SL; Rizopoulos D; du Marchie Sarvaas GJ; Backx AP; Ten Harkel AD; van Iperen GG; Rammeloo LA; Tanke RB; Boersma E; Helbing WA; Dalinghaus M
Am J Cardiol; 2016 Dec; 118(11):1723-1729. PubMed ID: 27692597
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of serial serum N-terminal prohormone brain natriuretic peptide levels in the prediction of outcome in children with dilated cardiomyopathy.
Kim G; Lee OJ; Kang IS; Song J; Huh J
Am J Cardiol; 2013 Nov; 112(9):1455-60. PubMed ID: 24035042
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm.
Tigen K; Karaahmet T; Kahveci G; Tanalp AC; Bitigen A; Fotbolcu H; Bayrak F; Mutlu B; Basaran Y
Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
D'Amato R; Tomberli B; Castelli G; Spoladore R; Girolami F; Fornaro A; Caldini A; Torricelli F; Camici P; Gensini GF; Cecchi F; Olivotto I
Am J Cardiol; 2013 Oct; 112(8):1190-6. PubMed ID: 23871673
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
Bruch C; Reinecke H; Stypmann J; Rothenburger M; Schmid C; Breithardt G; Wichter T; Gradaus R
J Heart Lung Transplant; 2006 Sep; 25(9):1135-41. PubMed ID: 16962477
[TBL] [Abstract][Full Text] [Related]
7. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.
Nasser N; Perles Z; Rein AJJT; Nir A
Pediatr Cardiol; 2006; 27(1):87-90. PubMed ID: 16132296
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults With Congenital Heart Disease.
Popelová JR; Kotaška K; Tomková M; Tomek J
Am J Cardiol; 2015 Nov; 116(9):1425-30. PubMed ID: 26404943
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
[TBL] [Abstract][Full Text] [Related]
10. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
11. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
[TBL] [Abstract][Full Text] [Related]
12. Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level.
Kim H; Shin HW; Son J; Yoon HJ; Park HS; Cho YK; Han CD; Nam CW; Hur SH; Kim YN; Kim KB
Congest Heart Fail; 2010; 16(4):153-8. PubMed ID: 20662867
[TBL] [Abstract][Full Text] [Related]
13. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
14. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
Eggers KM; Venge P; Lind L
Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
16. Change in N-terminal pro B-type natriuretic peptide levels and clinical outcomes in children undergoing congenital heart surgery.
Gupta RK; Zheng H; Cui Y; Qu J; Li L; Liang H; Li K; Chen X; Xia H
Int J Cardiol; 2019 May; 283():96-100. PubMed ID: 30833104
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease.
Baggen VJM; Baart SJ; van den Bosch AE; Eindhoven JA; Witsenburg M; Cuypers JAAE; Roos-Hesselink JW; Boersma E
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581225
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
Sroubek J; Matos J; Locke A; Kaplinskiy V; Levine YC; Shen C; Buxton AE
Heart Rhythm; 2021 Jan; 18(1):71-78. PubMed ID: 32866691
[TBL] [Abstract][Full Text] [Related]
19. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
[TBL] [Abstract][Full Text] [Related]
20. Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.
Gaggin HK; Truong QA; Rehman SU; Mohammed AA; Bhardwaj A; Parks KA; Sullivan DA; Chen-Tournoux A; Moore SA; Richards AM; Troughton RW; Lainchbury JG; Weiner RB; Baggish AL; Semigran MJ; Januzzi JL
Congest Heart Fail; 2013; 19(3):135-42. PubMed ID: 23279139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]